LIPPMAN EVAN (EVP, Business Development) sold 42.1% of their position (18.60K shares) of TEVA PHARMACEUTICAL INDUSTRIES LTD on the open market
Open‑market sale worth $680.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/19/2026ACC: 0001193125-26-356853
Officer· EVP, Business Development
Since Mar 2026
-18.60K
Net shares
Net seller
$680.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
18.60K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−18.60K
Price / share
$36.57
Trade value
$680.29K
% of position
42.1%
8/17/2026
44.19K→25.59K
Total
Net shares
−18.60K
Net value
-$680.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/17/2026 | S · Sale | −18.60K | $36.57 | $680.29K | 42.1% | 44.19K | 25.59K |
| Total | −18.60K | -$680.29K | ||||||
Derivative Transactions0
No derivative transactions reported